FINANCIAL RELEASES

Delivers revenue and EPS ahead of expectations, with total Invisalign® patients treated surpassing 15 million globally Completes May 13, 2021   $1 Billion Stock Repurchase Program Q1'23 total revenues of $943.1 million , increased 4.6% sequentially, and diluted net income per share of $1.14 ,

TEMPE, Ariz. --(BUSINESS WIRE)--Apr. 3, 2023-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Q4 total revenues of $901.5 million and 2022 total revenues of $3.7 billion Board of Directors has authorized a new $1 billion stock repurchase program, to succeed the current $1 billion program that is expected to be completed in Q2 2023   2022 total revenues of $3.7 billion , Clear Aligner

TEMPE, Ariz. --(BUSINESS WIRE)--Jan. 3, 2023-- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Company delivering on innovation roadmap; expanding geographically with first EMEA manufacturing facility; and celebrating 14 millionth Invisalign patient milestone Q3'22 total revenues of $890.3 million , and diluted net income per share of $0.93 Q3’22 revenues were unfavorably impacted by foreign

TEMPE, Ariz. --(BUSINESS WIRE)--Jul. 5, 2022-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Joe Hogan, president and CEO, intends to personally purchase $2.0 million of Align’s common stock TEMPE, Ariz., May 02, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of

Commemorates 25 years of smiles and innovation through doctor-directed care with major milestones including 217K Invisalign trained doctors, 12.8M Invisalign patients, 73K iTero scanners, and 49K exocad software licenses Q1'22 total revenues of $973.2 million, compared to $894.8 million in Q1'21

TEMPE, Ariz., April 05, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

Strengthens Align digital platform with major installed base milestones including 12M Invisalign patients, 68K iTero scanners, and 47K exocad software licenses 2021 total revenues up 59.9% to a record $4.0 billion, operating margin of 24.7%, in line with guidance 2021 revenue growth for the second

TEMPE, Ariz., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative

TEMPE, Ariz., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative

TEMPE, Ariz., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

Achieves 11 Millionth Invisalign Patient Milestone iTero Scanner Installed-base Reaches 50,000 Units Worldwide Q3 total revenues up 38.4% year-over-year to record $1.016 billion and up 0.5% sequentially Q3 diluted net income per share of $2.28; Q3 non-GAAP diluted net income per share of $2.87 Q3

TEMPE, Ariz., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

TEMPE, Ariz., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

TEMPE, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

TEMPE, Ariz., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

Q2 total revenues up 13.0% sequentially and 186.9% year-over-year to a record $1.0 billion Q2 diluted net income per share of $2.51; Q2 non-GAAP diluted net income per share of $3.04 Q2 operating margin of 26.6%, up 1.4 points sequentially and up 47.3 points year-over-year Q2 Clear Aligner revenues

TEMPE, Ariz., July 01, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and